Progressive MS: Markers of inflammation decrease after two doses of stem cell therapy
Two doses of an investigatio
nal stem cell therapy given eight weeks apart reduced the levels of four inflammatory biomarkers in the cerebrospinal fluid (CSF) of people with progressive forms of multiple sclerosis, although levels of another marker of inflammation increased, researchers report.
https://mymsaa.org/news/whats-new-in...july-2022/#pms
Two doses of an investigatio
nal stem cell therapy given eight weeks apart reduced the levels of four inflammatory biomarkers in the cerebrospinal fluid (CSF) of people with progressive forms of multiple sclerosis, although levels of another marker of inflammation increased, researchers report.
https://mymsaa.org/news/whats-new-in...july-2022/#pms
Comment